Form 4: Interparfums Director Acquires 1,500 Stock Options
Insider Transaction Report
Interparfums Director and 10% Owner Francois Heilbronn acquired 1,500 stock options under a pre-arranged plan, adding to existing equity holdings.
Summary
- Francois Heilbronn, a Director and 10% Owner of Interparfums Inc. (IPAR), reported changes in beneficial ownership.
- On December 31, 2025, Mr. Heilbronn acquired 1,500 stock options with an exercise price of $84.64 per share.
- These newly acquired options vest annually from December 31, 2026, to December 31, 2030, and expire on December 30, 2031.
- The acquisition was made pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
- Following this transaction, Mr. Heilbronn directly beneficially owns 28,563 shares of common stock.
- He also holds a total of 7,500 shares underlying various other stock options with exercise prices ranging from $62.18 to $147.71, and expiration dates up to December 30, 2031.
Sentiment
Score: 6
Explanation: The acquisition of stock options by a director is generally viewed as a neutral to slightly positive signal, indicating continued alignment with shareholder interests and confidence in the company's future. The transaction being under a 10b5-1 plan further neutralizes any immediate speculative interpretation.
Positives
- Director Heilbronn acquired 1,500 new stock options, indicating continued alignment of interests with shareholders and confidence in the company's future.
- The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned, non-discretionary acquisition.
Future Outlook
The acquisition of stock options with vesting schedules extending to 2030 and expiration dates to 2031 suggests a long-term commitment by the director to the company's future performance.
Industry Context
This filing reflects standard executive compensation practices within the consumer discretionary sector, where equity-based incentives are commonly used to align management and director interests with long-term shareholder value.
Comparison to Industry Standards
- The grant of stock options to a director is a common practice in publicly traded companies, including those in the fragrance and cosmetics industry like Interparfums.
- Companies such as Estée Lauder (EL) and Coty Inc. (COTY) also utilize equity compensation plans to incentivize their leadership.
- The specific terms, such as exercise price and vesting schedule, are generally benchmarked against peer group practices to ensure competitive compensation and retention.
Stakeholder Impact
- Shareholders: The acquisition of options by a director aligns their interests with shareholders, as the options gain value if the stock price increases.
- Employees: No direct impact on general employees is indicated.
Next Steps
- Future vesting of the newly acquired 1,500 stock options annually from December 31, 2026, to December 31, 2030.
- Potential exercise of various stock options by the reporting person as they become exercisable and prior to their expiration dates.
Key Dates
| Date | Description |
|---|---|
| 02/01/2022 | Transaction date for a tranche of options with $62.18 exercise price. |
| 12/31/2023 | Transaction date for a tranche of options with $97.84 exercise price. |
| 12/29/2024 | Transaction date for a tranche of options with $147.71 exercise price. |
| 12/31/2025 | Date of earliest transaction reported; transaction date for the acquisition of 1,500 stock options with an exercise price of $84.64, and transaction date for a tranche of options with $130.6 exercise price. |
| 01/05/2026 | Date the Form 4 was signed by Francois Heilbronn's attorney-in-fact. |
| 01/31/2026 | Expiration date for options with $62.18 exercise price. |
| 12/30/2028 | Expiration date for options with $97.84 exercise price. |
| 12/28/2029 | Expiration date for options with $147.71 exercise price. |
| 12/30/2030 | Expiration date for options with $130.6 exercise price. |
| 12/30/2031 | Expiration date for options with $84.64 exercise price. |
Recommendation
holdThis Form 4 filing reports a routine grant of stock options to a director under a pre-arranged 10b5-1 plan. While it indicates continued insider alignment, it does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should maintain their current position based on broader company fundamentals and market conditions.
Keywords
Interparfums, IPAR, SEC Form 4, Insider Transaction, Stock Options, Beneficial Ownership, Director, Equity Compensation, Rule 10b5-1, Francois Heilbronn
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.